% Expired Patents = 60.0

Forward Citations = 1

Loading Chart...

10 inventors (with patents filed for the assignee):

Paul R Sanberg (5 out of 59 patents)

Svitlana Garbuzova-Davis (4 out of 7 patents)

Jared Carl Ehrhart (3 out of 4 patents)

4. Alison Elizabeth Willing (2 out of 8 patents)

5. Andrew E Balber (1 out of 4 patents)

6. Juan Sanchez-Ramos (1 out of 9 patents)

7. Daniel D Richard (1 out of 15 patents)

8. Tracy Gentry (1 out of 3 patents)

9. Cyndy Davis-Sanberg (1 out of 1 patent)

10. Nicole Kuzmin-Nichols (1 out of 1 patent)

5 patents: Sort by Forward Citations

1. 12144832 - Plasma derived from human umbilical cord blood for the treatment of neurodegenerative disorders (2024-11-19),

2. 11628190 - Plasma derived from human umbilical cord blood for the treatment of neurodegenerative disorders (2023-04-18),

3. 11007230 - Plasma derived from human umbilical cord blood for the treatment of neurodegenerative disorders (2021-05-18),

4. 9795637 - Human cord blood as a source of neural tissue repair of the brain and spinal cord (2017-10-24),

5. 8765119 - Treating amyotrophic lateral sclerosis (ALS)with isolated aldehyde dehydrogenase-positive umbilical cord blood cells (2014-07-01),

Company Overview

Saneron CCEL Therapeutics, Inc. is a biotechnology company focused on developing innovative cell-based therapies for neurological disorders. We specialize in cell therapy research and have a strong track record of advancing treatments for conditions such as spinal cord injury, stroke, and ALS. Our cutting-edge technology and dedicated team of experts strive to make a meaningful impact on patients' lives.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

5 Patents

#95 in Tampa, FL

#1,716 in Florida

#51,644 in US

Tampa, FL, United States of America

Saneron Ccel Therapeutics, Inc.

Forward Citations = 1

10 inventors:

Paul R Sanberg (5 out of 59 patents)

Svitlana Garbuzova-Davis (4 out of 7 patents)

Jared Carl Ehrhart (3 out of 4 patents)

4. Alison Elizabeth Willing (2 out of 8 patents)

5. Andrew E Balber (1 out of 4 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Saneron Ccel Therapeutics, Inc.. Retrieved from https://idiyas.com/company/saneron-ccel-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]